Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

about

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

Item

http://www.wikidata.org/entity/Q46837495

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@en

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@nl

type

Item

label

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@en

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@nl

prefLabel

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@en

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@nl

P1476

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

@en

P2093

Kim S Smith

http://www.w3.org/2001/XMLSchema#string

Roberta A Thomas

http://www.w3.org/2001/XMLSchema#string

Rogely W Boyce

http://www.w3.org/2001/XMLSchema#string

Rosanna C Mirabile

http://www.w3.org/2001/XMLSchema#string

Sabine Rehm

http://www.w3.org/2001/XMLSchema#string

Scot L Eustis

http://www.w3.org/2001/XMLSchema#string

Tracy L Gales

http://www.w3.org/2001/XMLSchema#string

P2860

Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration

Integrins: bidirectional, allosteric signaling machines

Anoikis mechanisms

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome

Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials.

Systemic vascular disease in male B6C3F1 mice exposed to particulate matter by inhalation: studies conducted by the National Toxicology Program.

Effects of cyclic strain on vascular cells.

Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications.

Drug-induced vascular injury--a quest for biomarkers.

P304

958-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/01926230701748230

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5751169

http://www.w3.org/2001/XMLSchema#string

P698

18098042

http://www.w3.org/2001/XMLSchema#string